Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price: ₹1,781.00
Market cap: ₹4,27,322 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 35.3×Sector 47.3×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Promoter Reclassification 1 Merger & Restructuring 1 Earnings Call 1 Credit Rating 1 Business Update 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Aug 2026 15:56 IST BSE

Annual General Meeting

Sun Pharmaceutical Industries Annual General Meeting

Sun Pharma seeks shareholder approval via postal ballot to reclassify three members of the 'Promoter Group' to the 'Public' category, effective upon requisite approval.

Read the filing ↗